After establishing that TNTs are involved in intercellular trafficking of mutant KRAS, we sought to determine whether the transfer of mutant KRAS to wild-type KRAS CRC cells can induce a lasting functional effect by dysregulating downstream molecular signaling in recipient cells. This evidence concerns the gene KRAS and colorectal carcinoma.